Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Genocea Biosciences (GNCA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart
Realtime quote and/or trade prices are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 33,292
  • Shares Outstanding, K 28,700
  • Annual Sales, $ 240 K
  • Annual Income, $ -49,570 K
  • 36-Month Beta 1.93
  • Price/Sales 136.80
  • Price/Cash Flow 0.00
  • Price/Book 8.73

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.03 +17.48%
on 11/06/17
1.52 -20.39%
on 10/23/17
-0.25 (-17.12%)
since 10/20/17
3-Month
1.03 +17.48%
on 11/06/17
5.70 -78.77%
on 09/12/17
-2.89 (-70.49%)
since 08/22/17
52-Week
1.03 +17.48%
on 11/06/17
7.29 -83.40%
on 04/25/17
-2.95 (-70.91%)
since 11/22/16

Most Recent Stories

More News
GENOCEA LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $500,000 In Genocea Biosciences, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Genocea Biosciences, Inc. ("Genocea" or the "Company") (NASDAQ:GNCA) of the January 2, 2018 deadline to seek the role...

GNCA : 1.21 (+4.31%)
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Genocea Biosciences, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 2, 2018

The following statement is being issued by Levi & Korsinsky, LLP:

GNCA : 1.21 (+4.31%)
Genocea to Present at 29th Annual Piper Jaffray Healthcare Conference

Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing neoantigen cancer vaccines, today announced that Chip Clark, president and chief executive officer, will participate in a...

GNCA : 1.21 (+4.31%)
RM LAW Announces Class Action Lawsuit Against Genocea Biosciences, Inc.

RM LAW, P.C. announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased Genocea Biosciences, Inc. (NASDAQ: GNCA) ("Genocea" or the "Company") securities between...

GNCA : 1.21 (+4.31%)
The Klein Law Firm Announces a Class Action Filed on Behalf of Genocea Biosciences, Inc. Shareholders and a Lead Plaintiff Deadline of January 2, 2018

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Genocea Biosciences, Inc. (NASDAQ:GNCA) who purchased shares between May 5, 2017 and September 25,...

GNCA : 1.21 (+4.31%)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Genocea Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline - GNCA

NEW YORK, NY / ACCESSWIRE / November 18, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against Genocea Biosciences, Inc. ("Genocea" or the "Company") (NASDAQ: GNCA) and certain...

GNCA : 1.21 (+4.31%)
GNCA INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Genocea Biosciences, Inc. and a Lead Plaintiff Deadline of January 2, 2018

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the U.S. District Court for the District of Massachusetts on behalf of investors who purchased Genocea...

GNCA : 1.21 (+4.31%)
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Genocea Bioscience, Inc. to Contact Brower Piven before the Lead Plaintiff Deadline in Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District...

GNCA : 1.21 (+4.31%)
SHAREHOLDER ALERT: Berger & Montague, P.C. Announces Investigation of Genocea Biosciences, Inc. (GNCA)

Berger & Montague, P.C. announced today that Genocea Biosciences, Inc. ("Genocea" or the "Company") (NASDAQ: GNCA) and some of its senior executives (collectively, "Defendants") have been accused of federal...

GNCA : 1.21 (+4.31%)
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Genocea Biosciences, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 2, 2018

The following statement is being issued by Levi & Korsinsky, LLP:

GNCA : 1.21 (+4.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Genocea Biosciences, Inc. is involved in developing vaccines. The company's proprietary discovery platform consists of AnTigen Lead Acquisition System which designs vaccines that stimulate T cell immunity. Its product portfolio which are in different clinical trials consist of GEN-003, HSV-2 infections,...

See More

Key Turning Points

2nd Resistance Point 1.36
1st Resistance Point 1.28
Last Price 1.21
1st Support Level 1.13
2nd Support Level 1.05

See More

52-Week High 7.29
Fibonacci 61.8% 4.90
Fibonacci 50% 4.16
Fibonacci 38.2% 3.42
Last Price 1.21
52-Week Low 1.03

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart